Food and Drug Administration, HHS.
The Food and Drug Administration (FDA) is announcing that Cyanotech Corp. has filed a petition proposing that the food additive regulations be amended to provide for the safe use of Haematococcus algae astaxanthin as a nutrient supplement.Start Further Info
FOR FURTHER INFORMATION CONTACT:
James C. Wallwork, Center for Food Safety and Applied Nutrition (HFS-215), Food and Drug Administration, 5100 Paint Branch Pkwy, College Park, MD 20740, 202-418-3078.End Further Info End Preamble Start Supplemental Information
Under the Federal Food, Drug, and Cosmetic Act (sec. 409(b)(5) (21 U.S.C. 348(b)(5))), notice is given that a food additive petition (FAP 2A4732) has been filed by Cyanotech Corp., c/o T. Todd Lorenz, 11034 West Ocean Air Dr., # 252, San Diego, CA 92130. The petition proposes to amend the food additive regulations in part 172 Food Additives Permitted for Direct Addition to Food for Human Start Printed Page 17701Consumption (21 CFR part 172) to provide for the safe use of Haematococcus algae astaxanthin as a nutrient supplement.
The agency has determined under 21 CFR 25.32(r) that this action is of a type that does not individually or cumulatively have a significant effect on the human environment. Therefore, neither an environmental assessment nor an environmental impact statement is required.Start Signature
Dated: March 29, 2002.
Leslye M. Fraser,
Acting Director of Regulations and Policy, Center for Food Safety and Applied Nutrition.
[FR Doc. 02-8746 Filed 4-10-02; 8:45 am]
BILLING CODE 4160-01-S